Bostom AG, et al.. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation Trial. Circulation 2011; 123:1763–1770.
Kuro-O MA phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease. Kidney Int Suppl 2011; 3:420–426.